Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions
暂无分享,去创建一个
H. McFarland | D. McFarlin | R. Martin | L. Stone | H. Maloni | J. Frank | R. Martin | M. Smith | P. Albert | M. Armstrong | M. E. Smith | L. A. Stone | P. S. Albert | J. A. Frank | M. Armstrong | H. Maloni | D. E. McFarlin | H. F. McFarland | M. E. Smith | Maria G McFarland | MD R. Martin | MD M. E. Smith | MD L. A. Stone | PhD P. S. Albert | MD J. A. Frank | MD M. Armstrong | E. H.MaloniRND. | MD H. F McFarlin
[1] A. Thompson,et al. Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration , 1992, Neurology.
[2] D. McFarlin,et al. Multiple sclerosis (first of two parts). , 1982, New England Journal of Medicine.
[3] L Bozzao,et al. SPECT, MRI and cognitive functions in multiple sclerosis. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[4] D. Li,et al. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients , 1989, Annals of neurology.
[5] J. Oger,et al. Multiple sclerosis , 1988, Neurology.
[6] P. Scheltens,et al. Quantitative MRI changes in gadolinium‐DTPA enhancement after high‐dose intravenous methylprednisolone in multiple sclerosis , 1991, Neurology.
[7] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[8] V. Haughton,et al. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis , 1989, Neurology.
[9] A. Thompson,et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[10] F. Barkhof,et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. , 1992, AJR. American journal of roentgenology.
[11] B E Kendall,et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.
[12] Roland Martin,et al. Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.
[13] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[14] D. Thomas,et al. A Gibbs sampling approach to linkage analysis. , 1992, Human heredity.
[15] A. Thompson,et al. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[16] W. I. McDonald,et al. Heterogeneity of blood‐brain barrier changes in multiple sclerosis , 1990, Neurology.
[17] R. Murray,et al. The effect of high‐dose steroids on MRI gadolinium enhancement in acute demyelinating lesions , 1991, Neurology.
[18] D. McFarlin,et al. Multiple sclerosis (second of two parts). , 1982, The New England journal of medicine.
[19] F. Barkhof,et al. A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone , 1992, Neurology.
[20] N. Patronas,et al. Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history , 1991, Annals of neurology.
[21] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[22] C. Pozzilli,et al. Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis , 1990, Neurology.
[23] S W Atlas,et al. Multiple sclerosis: gadolinium enhancement in MR imaging. , 1986, Radiology.
[24] F. Mcdowell,et al. PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS , 1965, Annals of the New York Academy of Sciences.
[25] B E Kendall,et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.
[26] R. Capra,et al. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis. , 1992, Archives of neurology.